Pharmafile Logo

New Webinar: 2026 Engagement Strategies For Modern Pharma

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

- PMLiVE

Why sink your entire budget into a one-off webinar that is forgotten the moment the “End Meeting” button is clicked? 2026 engagement will be defined by longitudinal strategy delivered in snackable doses. In a world that is always on, learn how to build an ecosystem where global stakeholders collaborate across 100+ languages and time zones, utilizing micro-modules and gamification to keep your brand at the center of the conversation and continuously gather insights all year long.

Join us on March 3 – 4 to master modern pharma strategies that eliminate content fatigue and turn longitudinal interaction into actionable clinical insights. Among other topics, we’ll cover how to:

  • Bridge the 2026 Engagement Gap: Move from “pushed” content to high-value “pull” experiences, evolving your strategy from passive webinars to immersive, longitudinal journeys.

  • Generate Interaction Insights: Move beyond vanity metrics to measure “Clinical Conviction.” Leverage AI summaries and instant data reporting to quantify changes in HCP treatment priorities.

  • Turn Digital Fatigue into Digital Magnetism: Discover how snackable microlearning3D HolovisionInteractive SlidesAI Avatars, and VR/AR for MOA visualization can spike knowledge retention by up to 70%.

  • Empower Key Initiatives: See how new virtual tools enhance everything from Advisory Boards and Global Investigator Meetings to Agile MSL Enablement and Product Launch Orchestration.

And so much more!

Click here to register!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...